Human Metabolome Technologies, Inc. (6090) Other
Market cap
¥3.7B
P/E ratio
17.3x
Provides high-sensitivity analysis of metabolic compounds to pharmaceutical companies, research institutions, and manufacturers to support drug development and product testing.
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2019/06 | 2020/06 | 2021/06 | 2022/06 | 2023/06 | 2024/06 | 2025/06 | |
| Return on Assets | - | - | - | - | 5.4 | 5.7 | 6.6 | 4.7 | -9.3 | -3 | 3.7 | 14.5 | 13.1 | 9.9 | 10.3 |
| Return on equity (%) | - | - | - | ||||||||||||
| Employees | 45 | 47 | 50 | 59 | 63 | 54 | 61 | - | 80 | 73 | 69 | 65 | 57 | 58 | 62 |
| Total payout ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 99.4 |